Skip to content

KiOmed Pharma

Active
Rue Haute Claire 4 ·4041 Herstal, Belgium
KBO/BCE: BE 0846.318.862
Watch Print / PDF
Belgian State Gazette acts: 0 of 23 read
Age14 yrs
Real estate2 parcels · 2.3 ha

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of KiOmed Pharma is 0.4% (very low). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 02-06-2026 59 d early 2026-00132153
31-12-2024 31-07-2025 20-06-2025 41 d early 2025-00163632
31-12-2023 31-07-2024 05-06-2024 56 d early 2024-00115460
31-12-2022 31-07-2023 09-06-2023 52 d early 2023-00116021
31-12-2021 31-07-2022 22-06-2022 39 d early 2022-20081190
31-12-2020 31-07-2021 23-07-2021 8 d early 2021-38500141
31-12-2019 31-07-2020 10-07-2020 21 d early 2020-30900243
31-12-2018 31-07-2019 25-06-2019 36 d early 2019-23300316
31-12-2017 31-07-2018 20-06-2018 41 d early 2018-21700448
31-12-2016 31-07-2017 06-07-2017 25 d early 2017-27900395

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Established
Founded in 2012, 14 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.4% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Multiple establishment units +Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 volledig 02-06-2026 2026-00132153
31-12-2024 volledig 20-06-2025 2025-00163632
31-12-2023 volledig 05-06-2024 2024-00115460
31-12-2022 volledig 09-06-2023 2023-00116021
31-12-2021 volledig 22-06-2022 2022-20081190
31-12-2020 volledig 23-07-2021 2021-38500141
31-12-2019 volledig 10-07-2020 2020-30900243
31-12-2018 volledig 25-06-2019 2019-23300316
31-12-2017 volledig 20-06-2018 2018-21700448
31-12-2016 volledig 06-07-2017 2017-27900395

Directors

Directors & mandates

20 directors
23 of this company's 23 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing below: a director who resigned there may therefore still show here as sitting. See the acts under Publications.
Current directors & mandates
  • Clarentis Sri
    Director
    State Gazette act 25121527 (25-09-2025)
    Current
    25-09-2025 → present
  • VALOIS
    Administrateur non statutaire
    State Gazette act 25321883 (31-03-2025)
    Current
    31-03-2025 → present
  • SPARAXIS S.A.
    Director
    State Gazette act 24133616 (13-09-2024)
    Current
    13-09-2024 → present
  • Benoît Fellin
    Director
    State Gazette act 23106635 (16-08-2023)
    Current
    16-08-2023 → present
  • Caroline Thielen
    Director
    State Gazette act 23106635 (16-08-2023)
    Current
    16-08-2023 → present
  • François Blondel
    Président exécutif du conseil d'administration
    State Gazette act 23106635 (16-08-2023)
    Current
    16-08-2023 → present
    2 events
    • 16-08-2023 Appointed· Président exécutif du conseil d'administration
    • 30-05-2016 Resigned· Director
Show 6 more sitting directors
  • Houtaï Choumane
    Managing director
    State Gazette act 23106635 (16-08-2023)
    Current
    16-08-2023 → present
  • Marie Hobe
    Director
    State Gazette act 23106635 (16-08-2023)
    Current
    16-08-2023 → present
  • Chagral Invest SRLLegal entity
    Director
    State Gazette act 25121527 (25-09-2025)
    Current
    01-06-2023 → present
    2 events
    • 25-09-2025 Appointed· Director
    • 01-06-2023 Appointed· Director
  • Samanda S.A.
    Director
    State Gazette act 23071547 (01-06-2023)
    Current
    01-06-2023 → present
  • Dr Pierre Rigaux
    Administrateur indépendant
    State Gazette act 20118180 (09-10-2020)
    Current
    09-10-2020 → present
  • Marc Nolet
    Director
    State Gazette act 23106635 (16-08-2023)
    Current
    10-03-2020 → present
    3 events
    • 16-08-2023 Appointed· Director
    • 10-03-2020 Resigned· Director
    • 10-03-2020 Appointed· Director
Historic, not recently confirmed (5)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Marc NOLET de BRAUWERE van STEELAND
    Director
    State Gazette act 16093242 (06-07-2016)
    Not recently confirmed
    last confirmed in an act from 2016
  • INNODE SALegal entity
    Director
    State Gazette act 16073900 (30-05-2016)
    Not recently confirmed
    last confirmed in an act from 2016
  • KiOmed Pharma
    Commis
    State Gazette act 15176734 (18-12-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • Monsieur Philippe Pire
    Auditor
    State Gazette act 15176734 (18-12-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • S.C.R.L. ERNST & YOUNG REVISEURS D'ENTREPRISE
    Auditor
    State Gazette act 15176734 (18-12-2015)
    Not recently confirmed
    last confirmed in an act from 2015
Permanent representatives (4)
These people represent a legal-person director (a management company, for instance). They hold no board mandate of their own and do not count as directors.
  • Caroline Thielen
    Représentant permanent
    State Gazette act 24133616 (13-09-2024)
    Permanent representative
    22-09-2021 → present
    2 events
    • 13-09-2024 Appointed· Représentant permanent
    • 22-09-2021 Appointed· Representant permanent
  • Benoit Fellin
    Représentant permanent
    State Gazette act 20037976 (10-03-2020)
    Permanent representative
    10-03-2020 → present
  • Françoise Leblanc
    Représentant permanent
    State Gazette act 20037976 (10-03-2020)
    Permanent representative
    - → 10-03-2020
  • Géry Lefebvre
    Representant permanent
    State Gazette act 21113286 (22-09-2021)
    Permanent representative
    - → 22-09-2021
Former directors (3)
  • SPARAXIS
    Director
    State Gazette act 25321883 (31-03-2025)
    Former
    - → 31-03-2025
  • Flexximum R&D srlLegal entity
    Director
    State Gazette act 20118180 (09-10-2020)
    Former
    - → 09-10-2020
  • Géry LEFEBVRE
    Director
    State Gazette act 16093242 (06-07-2016)
    Former
    06-07-2016 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Statutory auditor

4 auditors
Statutory auditor IRE/IBR number Tenure
EYCurrent
Commissaire aux comptes
 - 22-09-2021 → present
Show 3 earlier auditors
Ernst & Young
Commissaire aux comptes
succeeded by EY in 2021
 - 10-03-2020 → 22-09-2021
EY Réviseurs d'Entreprises SRL
Commissaire
 - - → 13-09-2024
Marie-Laure Moreau
Commissaire
succeeded by Ernst & Young in 2020
 - 25-08-2017 → 10-03-2020
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied(72109)
Legal form Public limited company(014)
Incorporation04-06-2012
StatusActive
Postal code4041

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

2 locations
KiOmed Pharma S.A.
Rue Haute Claire 4, 4041 HerstalVervaardiging van overige geneesmiddelen, inclusief homeopathische bereidingen
since 20122.230.381.673
KiOmed Pharma
Boulevard de Patience et Beaujonc 3, 4000 LiègeVervaardiging van overige geneesmiddelen, inclusief homeopathische bereidingen
since 20242.378.241.545
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area2.3 ha
Buildings1
Building footprint851 m²
Volume (LiDAR)5,573 m³
Tallest building7.2 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62042B0366/00B003 Wallonia 1.9 ha - -
62071B0791/00G004 Wallonia 4,437 m² 1 · 850 m² 7.2 m · 2 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

19 acts
Capital history · 6
31-03-2025
v3.2
09-07-2021
v3.2
07-08-2019
v3.2
28-05-2019
v3.2
20-05-2019
v3.2
10-12-2018
v3.2
All acts · 19 updated 11 months ago
2025
25-09-2025 2 directors appointed Director changes
  • Chagral Invest SRL, Bestuurder
  • Clarentis Sri, Bestuurder
Summary: v3.2
31-03-2025 Capital increase of €6,046,834.90 to €14,726,836.31 Capital & shares
  • €8.680.001,41 → €14.726.836,31
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
16-01-2025 Articles of association amended Statutes amendment
Summary: v3.2
2024
13-09-2024 2 directors appointed, 1 resigning Director changes
  • SPARAXIS S.A., Bestuurder
  • Caroline Thielen, Représentant permanent
  • EY Réviseurs d'Entreprises SRL, Commissaire
Summary: v3.2
2023
16-08-2023 6 directors appointed Director changes
  • François Blondel, Président exécutif du conseil d'administration
  • Houtaï Choumane, Gedelegeerd bestuurder
  • Caroline Thielen, Bestuurder
  • Benoît Fellin, Bestuurder
  • Marc Nolet, Bestuurder
  • Marie Hobe, Bestuurder
Summary: v3.2
01-06-2023 2 directors appointed Director changes
  • Chagral Invest Srl, Bestuurder
  • Samanda S.A., Bestuurder
Summary: v3.2
2022
03-01-2022 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Ariane DENIS
Summary: otherNotary: Ariane DENIS · LiègeFirm: Yves Godin & Ariane Denis, Notaires Associés SRL
2021
22-09-2021 2 directors appointed, 1 resigning Director changes
  • Caroline Thielen, Representant permanent
  • EY, Commissaire aux comptes
  • Géry Lefebvre, Representant permanent
Summary: v3.2
09-07-2021 Capital increase of €174,000 to €5,350,528.90 Capital & shares
  • €5.176.528,90 → €5.350.528,90
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
2020
09-10-2020 1 director appointed, 1 resigning Director changes
  • Dr Pierre Rigaux, Administrateur indépendant
  • Flexximum R&D srl, Bestuurder
Summary: v3.2
10-03-2020 3 directors appointed, 2 resigning Director changes
  • Marc Nolet, Bestuurder
  • Benoit Fellin, Représentant permanent
  • Ernst & Young, Commissaire aux comptes
  • Marc Nolet, Bestuurder
  • Françoise Leblanc, Représentant permanent
Summary: v3.2
2019
07-08-2019 Capital increase of €985,422.07 to €5,176,528.90 Capital & shares
  • €4.191.106,83 → €5.176.528,90
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
28-05-2019 Capital decrease of €4,313,637.52 to €4,191,106.83 Capital & shares
  • €8.504.744,35 → €4.191.106,83
Summary: v3.2
20-05-2019 Capital increase of €120 to €8,504,744.35 Capital & shares
  • €8.504.624,35 → €8.504.744,35
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
2018
10-12-2018 Transaction in capital or shares Capital & shares
Summary: v3.2
2017
25-08-2017 Marie-Laure Moreau appointed as commissaire Director changes
  • Marie-Laure Moreau, Commissaire
Summary: v3.2
2016
06-07-2016 Articles of association amended Statutes amendment
Summary: v3.2
30-05-2016 1 director appointed, 1 resigning Director changes
  • INNODE SA, Bestuurder
  • François BLONDEL, Bestuurder
Summary: v3.2
2015
18-12-2015 3 directors appointed Director changes
  • KiOmed Pharma, Commis
  • S.C.R.L. ERNST & YOUNG REVISEURS D'ENTREPRISE, Auditor
  • Monsieur Philippe Pire, Auditor
Summary: v3.2

Analysis

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector and region
We hold no filed accounts for this company, so a size comparison is not possible. These companies share only the sector and the region. We hold annual accounts for 148 of the 1,175 companies in this sector.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Niet-gespecialiseerde groothandel46900
Primary activity highlighted.
Names & trade names
Legal nameFR KiOmed Pharma
Registered office
Rue Haute Claire 4
4041 Herstal, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.